Concurrently, catecholamines exacerbate insulin resistance by promoting lipolysis in adipose tissue (6, 7) and impairing insulin-mediated glucose uptake in skeletal muscle (6, 8) through α1- and β-receptors. Here, INS is linked to Insulin resistance.